Form 4: Sabra Health Care CEO Boosts Stake with Dividend Equivalents

Sabra Health Care REIT's Chair, CEO, and President, Richard K. Matros, acquired 13,141 common stock units through dividend equivalent payments.

Summary

• Richard K. Matros, Chair, CEO, and President of Sabra Health Care REIT, Inc. (SBRA), acquired 13,141 shares of common stock.
• The acquisition occurred on November 28, 2025, at a price of $0 per share.
• These shares represent stock units credited as dividend equivalent payments on previously granted stock units under the company's 2009 Performance Incentive Plan.
• The newly acquired units will vest and become payable under the same terms as the original stock units.
• Following this transaction, Matros directly beneficially owns 867,789 common stock units and indirectly owns 1,624,750 common stock units through the R&A Matros Revocable Trust.

Sentiment

Score: 7

Explanation: The acquisition of additional stock units by the CEO, even if through dividend equivalents, generally indicates a positive alignment of interests and continued confidence in the company. It's a routine, non-cash transaction, so the positive impact is moderate.

Positives

• Increased beneficial ownership by a key executive (Chair, CEO, and President) signals confidence in the company's future.
• The acquisition of stock units through dividend equivalents indicates ongoing participation in the company's performance incentive plan and benefits from dividend distributions.

Future Outlook

The filing does not provide specific forward-looking statements or guidance beyond the vesting terms of the acquired stock units, which will vest and become payable on the same terms as the original units.

Industry Context

This Form 4 reports an insider transaction for a healthcare REIT. Such transactions, particularly acquisitions of stock units through compensation plans, are common across the REIT sector and generally reflect standard executive compensation practices tied to company performance and dividend distributions. It does not provide broader industry trends.

Comparison to Industry Standards

• This transaction is a routine insider filing (Form 4) reporting the acquisition of stock units as dividend equivalents, which is a standard component of executive compensation plans in many publicly traded companies, including REITs.
• It does not provide specific financial results or operational metrics for direct comparison to industry benchmarks or competitors like Ventas (VTR) or Welltower (WELL) in terms of performance, but rather details an executive's equity holdings.

Corporate Governance

Related Party Transactions

• The indirect beneficial ownership of 1,624,750 common stock units is held through the R&A Matros Revocable Trust, which is a related party to Richard K. Matros.

Stakeholder Impact

• Shareholders: Increased alignment of executive interests with shareholders through greater equity ownership.
• Employees: No direct impact on general employees.

Next Steps

• The acquired stock units will vest and become payable on the same terms as the original stock units to which they relate.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of stock units by the CEO as dividend equivalents, which is a standard part of executive compensation and indicates continued alignment with shareholder interests. It does not provide new financial performance data or strategic shifts that would warrant a change in investment recommendation. Investors should continue to hold based on broader company fundamentals and market conditions, as this specific filing offers no new catalysts for a 'buy' or 'sell' decision.

Keywords

Sabra Health Care REIT, SBRA, Richard K. Matros, Insider Trading, Form 4, Stock Units, Dividend Equivalents, Executive Compensation, REIT, Healthcare REIT